Author

Wan‐Ju Lee

Observed names: Wan-Ju Lee, Wan-Ju Lee (7994084), Wan-Ju Lee

Observed institutions: Boston University, Asia University, Edward Hines, Jr. VA Hospital, Mackay Memorial Hospital, AbbVie (United States), University of Illinois Chicago, Fred Hutch Cancer Center, National Defense Medical Center, Medical University of Vienna, Icahn School of Medicine at Mount Sinai

ORCID: 0000-0001-9263-6943

Observed ORCIDs: 0000-0001-9263-6943, 0000-0002-2776-7223

OpenAlex ID: A5014100389

Outcomes and Strategies to Support a Treat-to-target Approach in Inflammatory Bowel Disease: A Systematic Review

2019 · Jean-Frédéric Colombel, Geert D’haens, et al. · Journal of Crohn s and Colitis · 284

PDF

Antithyroid drug‐related hepatotoxicity in hyperthyroidism patients: a population‐based cohort study

2014 · Meng‐Ting Wang, Wan‐Ju Lee, et al. · British Journal of Clinical Pharmacology · 114

PDF

Systematic review and meta‐analysis: efficacy and safety of early biologic treatment in adult and paediatric patients with Crohn’s disease

2020 · Ryan C Ungaro, Saurabh Aggarwal, et al. · Alimentary Pharmacology & Therapeutics · 110

Long-Term Safety and Efficacy of Risankizumab Treatment in Patients with Crohn’s Disease: Results from the Phase 2 Open-Label Extension Study

2021 · Marc Ferrante, Brian G Feagan, et al. · Journal of Crohn s and Colitis · 73

PDF

Medication adherence and persistence over time with self-administered TNF-alpha inhibitors among young adult, middle-aged, and older patients with rheumatologic conditions

2017 · Gregory S. Calip, Sruthi Adimadhyam, et al. · Seminars in Arthritis and Rheumatism · 50

Polypharmacy and Adherence to Adjuvant Endocrine Therapy for Breast Cancer

2017 · Gregory S. Calip, Shan Xing, et al. · Journal of Oncology Practice · 46

Early and Sustained Improvements in Symptoms and Quality of Life with Upadacitinib in Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis: 52-Week Results from Two Phase III Randomized Clinical Trials (Measure Up 1 and Measure Up 2)

2024 · Jonathan I. Silverberg, Melinda J. Gooderham, et al. · American Journal of Clinical Dermatology · 44

PDF

Tight control for Crohn’s disease with adalimumab-based treatment is cost-effective: an economic assessment of the CALM trial

2019 · Remo Panaccione, Jean-Frederic Colombel, et al. · Gut · 36

PDF

Risk of serious bacterial infection associated with tumour necrosis factor-alpha inhibitors in children with juvenile idiopathic arthritis

2017 · Wan-Ju Lee, Todd A Lee, et al. · Lara D. Veeken · 36

Myelodysplastic syndrome and acute myeloid leukemia following adjuvant chemotherapy with and without granulocyte colony-stimulating factors for breast cancer

2015 · Gregory S. Calip, Judith A. Malmgren, et al. · Breast Cancer Research and Treatment · 33

Drugs Associated with Adverse Events in Children and Adolescents

2014 · Wan‐Ju Lee, Todd A. Lee, et al. · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · 31

Dose Escalation Patterns of Advanced Therapies in Crohn’s Disease and Ulcerative Colitis: A Systematic Literature Review

2023 · Remo Panaccione, Wan-Ju Lee, et al. · Advances in Therapy · 27

PDF

Effect of risankizumab on health‐related quality of life in patients with Crohn's disease: results from phase 3 MOTIVATE , ADVANCE and FORTIFY clinical trials

2022 · Laurent Peyrin‐Biroulet, Subrata Ghosh, et al. · Alimentary Pharmacology & Therapeutics · 27

Risk of stroke associated with inhaled ipratropium bromide in chronic obstructive pulmonary disease: A population-based nested case–control study

2012 · Meng-Ting Wang, Cheng-Liang Tsai, et al. · International Journal of Cardiology · 26

Top-down Versus Step-up Prescribing Strategies for Tumor Necrosis Factor Alpha Inhibitors in Children and Young Adults with Inflammatory Bowel Disease

2016 · Wan-Ju Lee, Leslie Briars, et al. · Inflammatory Bowel Diseases · 21

Economic Burden of Fatigue in Inflammatory Bowel Disease

2023 · Ashwin N Ananthakrishnan, Raj Desai, et al. · Crohn s & Colitis 360 · 17

PDF

Impact of Upadacitinib Induction and Maintenance Therapy on Health-related Quality of Life, Fatigue, and Work Productivity in Patients with Moderately-to-severely Active Crohn’s Disease

2024 · Subrata Ghosh, Brian G Feagan, et al. · Journal of Crohn s and Colitis · 16

Increased absolute lymphocyte count, increased absolute neutrophil count and low platelet to lymphocyte ratio as predicting factors in the superior disease control of refractory/relapsing gynecologic malignancies with anti PD-1 therapy: 10 years of experience in a single institution

2023 · Wan-Ju Lee, Yi-Lun Wang, et al. · Taiwanese Journal of Obstetrics and Gynecology · 16

Content Validity and Psychometric Evaluation of the Functional Assessment of Chronic Illness Therapy–Fatigue (FACIT–Fatigue) in Patients with Crohn’s Disease and Ulcerative Colitis

2023 · Edward V. Loftus, Ashwin N. Ananthakrishnan, et al. · PharmacoEconomics - Open · 16

PDF

Upadacitinib Rapidly Improves Patient-Reported Outcomes in Atopic Dermatitis: 16-Week Results from Phase 3 Clinical Trials (Measure Up 1 and 2)

2024 · Eric L. Simpson, Vimal H. Prajapati, et al. · Dermatology and Therapy · 15

PDF

Use of Tumor Necrosis Factor‐Alpha Inhibitors in Children and Young Adults With Juvenile Idiopathic Arthritis or Rheumatoid Arthritis

2016 · Wan‐Ju Lee, Leslie Briars, et al. · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · 15

Risk of Serious Bacterial Infection Associated With Tumor Necrosis Factor–Alpha Inhibitors in Children and Young Adults With Inflammatory Bowel Disease

2018 · Wan-Ju Lee, Todd A Lee, et al. · Inflammatory Bowel Diseases · 14

Extract of Monascus purpureus CWT715 Fermented from Sorghum Liquor Biowaste Inhibits Migration and Invasion of SK-Hep-1 Human Hepatocarcinoma Cells

2016 · Wen-Teish Chang, Cheng-Hung Chuang, et al. · Molecules · 13

PDF

Impact of Achieving Optimal Treatment Targets and Minimal Disease Activity on Health-Related Quality of Life and Satisfaction in Patients with Atopic Dermatitis

2025 · Jonathan I. Silverberg, Melinda Gooderham, et al. · Dermatology and Therapy · 11

PDF

Exposure to Sennoside–Digoxin Interaction and Risk of Digoxin Toxicity: A Population-Based Nested Case–Control Study

2011 · Meng-Ting Wang, I-Hsun Li, et al. · European Journal of Heart Failure · 11

PDF

Works count: 63

Citation count: 1,163

H-index: 16

I10-index: 25